Omeros Corp. (OMER)
12.05
+0.50
(+4.33%)
USD |
NASDAQ |
Feb 27, 16:00
12.06
0.00 (0.00%)
After-Hours: 20:00
Omeros Research and Development Expense (TTM) : 84.14M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Edgewise Therapeutics, Inc. | 149.30M |
| Boston Scientific Corp. | 2.052B |
| Gilead Sciences, Inc. | 5.688B |
| Merck & Co., Inc. | 12.71B |
| REGENXBIO, Inc. | 203.30M |